Macleods’ pretomanid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Revised NTD EOI published
M
On 29 October 2024, the revised 9th NTD EOI, now including Moxidectin, was published.
WHO grants approval for use of Bavarian Nordic’s mpox vaccine in adolescents
V
On 8 October 2024, WHO granted prequalification for the age-extension of the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for use in adolescents aged 12 to 17 years, expanding its indi
Lupin’s isoniazid/rifapentine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Recent Highlights
IVD
On 14 October 2024 WHO listed the second mpox IVD under the WHO Emergency Use Listing (EUL) procedure.
For Public Consultation: New proposed version of the Guidance on reportable changes to IVDs
IVD
WHO is seeking for public comments on a new proposed version of the Guidance on reportable changes to IVDs (deadline for submission of comments by 15 November 2024).
Public consultation on proposed revisions to the WHO Prequalification of in vitro diagnostics assessment process
IVD